Yongsheng W. Jia

Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Retraction notice to "Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5" [International Journal of Biological Macromolecules 280 (2024) 135655].

Retraction notice to "Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5" [International Journal of Biological Macromolecules 280 (2024) 135655].

Journal: International journal of biological macromolecules

Published: July 21, 2026

Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study.

Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study.

Journal: Frontiers in pharmacology

Published: November 30, 2025

Efficacy and safety of treatments in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor progression: a network meta-analysis and scoping review.

Efficacy and safety of treatments in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor progression: a network meta-analysis and scoping review.

Journal: BMC cancer

Published: September 19, 2025

Dalpiciclib plus fulvestrant and pyrotinib in HR+/HER2-low advanced breast cancer after progression on CDK4/6 inhibition (DapPLE-HER): a Bayesian optimal phase II study.

Dalpiciclib plus fulvestrant and pyrotinib in HR+/HER2-low advanced breast cancer after progression on CDK4/6 inhibition (DapPLE-HER): a Bayesian optimal phase II study.

Journal: International journal of surgery (London, England)

Published: June 19, 2025

Effect of oral nutritional intervention on recovery in patients with chyle leak after thyroid cancer surgery: A retrospective study.

Effect of oral nutritional intervention on recovery in patients with chyle leak after thyroid cancer surgery: A retrospective study.

Journal: Medicine

Published: February 10, 2025

CBX6 and CA9 as predictive indicators and therapeutic targets in GBM.

CBX6 and CA9 as predictive indicators and therapeutic targets in GBM.

Journal: Molecular therapy. Oncology

Published: January 08, 2025

Global Thyroid Cancer Patterns and Predictive Analytics: Integrating Machine Learning for Advanced Diagnostic Modelling.

Global Thyroid Cancer Patterns and Predictive Analytics: Integrating Machine Learning for Advanced Diagnostic Modelling.

Journal: Journal of cellular and molecular medicine

Published: December 30, 2024

Characterization of novel sialylation-associated microRNA signature for prognostic assessment in breast cancer and its implications for the tumor microenvironment.

Characterization of novel sialylation-associated microRNA signature for prognostic assessment in breast cancer and its implications for the tumor microenvironment.

Journal: The Journal of steroid biochemistry and molecular biology

Published: November 05, 2024

Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.

Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.

Journal: International journal of biological macromolecules

Published: July 18, 2024

A nomogram for predicting subsequent liver metastasis in patients with metastatic breast cancer.

A nomogram for predicting subsequent liver metastasis in patients with metastatic breast cancer.

Journal: Frontiers in oncology

Published: April 15, 2024

Study on the Influence of Temperature and Water Content on the Static Mechanical Properties of Sandstone.

Study on the Influence of Temperature and Water Content on the Static Mechanical Properties of Sandstone.

Journal: Materials (Basel, Switzerland)

Published: April 07, 2024

Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro.

Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro.

Journal: Analytical cellular pathology (Amsterdam)

Published: February 29, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026